Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of LX3305 in rheumatoid arthritis on stable methotrexate
2009-012705-19Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing LX3305 + methotrexate with Placebo + methotrexate (2 arms). Started Jul 2009; status: completed.
02
Drugs
lx3305
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-012705-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012705-19.